Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Aker BioMarine ASA's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Aker BioMarine ASA's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA FCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aker BioMarine ASA (STU:1PG) has a FCF Margin % of -19.97% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aker BioMarine ASA and its competitors. According to the industry distribution chart, Aker BioMarine ASA ranks #1554 out of 1958 companies in the Consumer Packaged Goods industry, placing it in the top 79.4%.
Is Aker BioMarine ASA's FCF Margin % too high?
Aker BioMarine ASA's current FCF Margin % is -19.97%. Based on the distribution chart, Aker BioMarine ASA ranks #1554 out of 1958 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Aker BioMarine ASA has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's FCF Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Aker BioMarine ASA ranks #1554 out of 1958 companies for FCF Margin %. This places Aker BioMarine ASA in the lower half of its industry. The industry median FCF Margin % is 2.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Consumer Packaged Goods company?
The median FCF Margin % among Consumer Packaged Goods companies is 2.19, based on 1,958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aker BioMarine ASA and its competitors. For the Consumer Packaged Goods industry, the median FCF Margin % is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aker BioMarine ASA's current FCF Margin % is -19.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (STU:1PG) is currently considered Significantly Overvalued. The stock's GF Value™ is €6.69, compared to a current price of €9.78 — trading 46.2% above its estimated fair value. The current FCF Margin % is -19.97%. Aker BioMarine ASA's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Aker BioMarine ASA (STU:1PG), the current FCF Margin % is -19.97% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aker BioMarine ASA (STU:1PG) Overvalued in 2026?
Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued.
The current stock price of €9.78 is trading 46.2% above its estimated GF Value™ of €6.69.
GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.
Key valuation signals for STU:1PG:
FCF Margin %: -19.97%
GF Value™: €6.69 vs. price of €9.78 (46.2% above fair value)
No single metric tells the full story. See the STU:1PG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
64GF Score
Get the complete analysis for STU:1PG
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:1PG has been successfully added to your 
